FDA declines to approve Intellipharma's opioid painkiller

loading...


FDA declines to approve Intellipharma’s opioid painkiller
(Reuters) – Intellipharmaceutics International Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve its long-acting opioid painkiller in its current form, backing its independent advisory panel that had raised concerns over the drug’s abuse-deterrence capabilities.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...